Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,072 | 4 | 59.7% |
| Food and Beverage | $4,889 | 267 | 36.1% |
| Education | $208.65 | 9 | 1.5% |
| Consulting Fee | $150.00 | 1 | 1.1% |
| Travel and Lodging | $143.58 | 1 | 1.1% |
| Gift | $65.50 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $8,717 | 18 | $0 (2024) |
| Alkermes, Inc. | $774.25 | 30 | $0 (2024) |
| Novo Nordisk Inc | $709.19 | 31 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $509.59 | 28 | $0 (2022) |
| Indivior Inc. | $353.85 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $318.46 | 19 | $0 (2023) |
| Allergan, Inc. | $235.39 | 11 | $0 (2020) |
| Orexo US, Inc. | $203.45 | 24 | $0 (2024) |
| USWM, LLC | $189.64 | 23 | $0 (2024) |
| Lundbeck LLC | $186.95 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $621.95 | 26 | Axsome Therapeutics, Inc. ($122.19) |
| 2023 | $9,120 | 36 | IDORSIA PHARMACEUTICALS US INC ($8,671) |
| 2022 | $778.42 | 35 | Alkermes, Inc. ($197.74) |
| 2021 | $763.04 | 54 | Ironshore Pharmaceuticals Inc. ($255.34) |
| 2020 | $859.98 | 52 | Novo Nordisk Inc ($182.99) |
| 2019 | $529.05 | 41 | Orexo US, Inc. ($118.46) |
| 2018 | $458.13 | 25 | Novo Nordisk Inc ($134.54) |
| 2017 | $397.99 | 14 | Alkermes, Inc. ($244.82) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: OUD | ||||||
| 11/15/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Addiction Medicine | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Obesity | ||||||
| 09/27/2024 | USWM, LLC | Lucemyra (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/20/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Opioid Use Disorder | ||||||
| 09/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: OUD | ||||||
| 09/06/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Addiction Medicine | ||||||
| 08/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.78 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/16/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: CNS | ||||||
| 06/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Opioid Use Disorder | ||||||
| 06/18/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CNS | ||||||
| 06/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Obesity | ||||||
| 05/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Opioid Use Disorder | ||||||
| 05/14/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: CNS | ||||||
| 05/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: OUD | ||||||
| 05/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: PSYCHIATRY | ||||||
| 04/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: OUD | ||||||
| 03/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Opioid Use Disorder | ||||||
| 02/23/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: CNS | ||||||
| 02/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Insomnia | ||||||
| 01/19/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,228 | 2,556 | $314,356 | $193,881 |
| 2022 | 14 | 1,167 | 2,518 | $306,759 | $186,096 |
| 2021 | 17 | 1,359 | 2,621 | $318,862 | $201,425 |
| 2020 | 12 | 951 | 2,253 | $257,133 | $132,953 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 273 | 923 | $133,286 | $71,965 | 54.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 557 | $88,556 | $63,329 | 71.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $34,356 | $22,420 | 65.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 64 | $15,589 | $10,624 | 68.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,340 | $4,932 | 52.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $6,000 | $4,674 | 77.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 192 | 461 | $4,610 | $3,872 | 84.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,940 | $3,118 | 79.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 69 | $3,376 | $2,449 | 72.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 65 | 66 | $3,300 | $2,092 | 63.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 109 | 112 | $7,088 | $1,525 | 21.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 20 | $2,543 | $1,522 | 59.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 28 | 34 | $1,750 | $1,032 | 58.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 25 | $620.83 | $328.81 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 994 | $144,611 | $81,827 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 443 | $73,471 | $50,036 | 68.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 142 | 142 | $33,149 | $21,769 | 65.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 64 | $15,901 | $10,898 | 68.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 33 | 33 | $8,250 | $6,519 | 79.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $3,550 | $2,764 | 77.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,726 | $2,735 | 57.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 60 | 60 | $2,778 | $2,023 | 72.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 22 | 22 | $3,300 | $1,876 | 56.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 123 | 132 | $8,344 | $1,778 | 21.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 51 | 51 | $2,550 | $1,528 | 59.9% |
About Dr. Stuart Wasser, MD
Dr. Stuart Wasser, MD is a Addiction Medicine healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922099852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Wasser, MD has received a total of $13,529 in payments from pharmaceutical and medical device companies, with $621.95 received in 2024. These payments were reported across 283 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,072).
As a Medicare-enrolled provider, Wasser has provided services to 4,705 Medicare beneficiaries, totaling 9,948 services with total Medicare billing of $714,354. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Internal Medicine
- Location Rockville Centre, NY
- Active Since 10/31/2005
- Last Updated 10/09/2025
- Taxonomy Code 207RA0401X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922099852
Products in Payments
- QUVIVIQ (Drug) $8,717
- JORNAY PM (Drug) $494.25
- Ozempic (Drug) $359.87
- VIVITROL (Drug) $335.86
- SUBLOCADE (Drug) $324.60
- VRAYLAR (Drug) $297.51
- REXULTI (Drug) $259.12
- Lucemyra (Drug) $242.97
- BELSOMRA (Drug) $210.28
- Zubsolv (Drug) $203.45
- Vivitrol (Drug) $156.42
- BRIXADI (Drug) $153.21
- Victoza (Drug) $146.36
- Vivitrol 380 mg (Drug) $131.97
- VYVANSE (Drug) $125.42
- Auvelity (Drug) $122.19
- Lucemyra/Lofexidine (Drug) $100.22
- Wegovy (Drug) $84.29
- JANUVIA (Drug) $78.05
- FARXIGA (Drug) $75.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.